Exact Sciences Co. Expected to Post Q2 2025 Earnings of $0.10 Per Share (NASDAQ:EXAS)

Exact Sciences Co. (NASDAQ:EXAS – Free Report) – Equities researchers at Leerink Partnrs reduced their Q2 2025 earnings per share estimates for shares of Exact Sciences in a note issued to investors on Tuesday, January 16th. Leerink Partnrs analyst P. Souda now anticipates that the medical research company will earn $0.10 per share for the […]

Leave a Reply

Your email address will not be published.

Previous post HC Wainwright Increases Apellis Pharmaceuticals (NASDAQ:APLS) Price Target to $92.00
Next post Research Analysts Issue Forecasts for Cargojet Inc.’s FY2024 Earnings (TSE:CJT)